Earnings Per Share, Diluted of Sunshine Biopharma Inc. from 31 Dec 2021 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Sunshine Biopharma Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Dec 2021 to 30 Jun 2025.
  • Sunshine Biopharma Inc. Earnings Per Share, Diluted for the quarter ending 30 Jun 2025 was -0.82, a 98% increase year-over-year.
  • Sunshine Biopharma Inc. annual Earnings Per Share, Diluted for 2024 was -7.32, a 98% increase from 2023.
  • Sunshine Biopharma Inc. annual Earnings Per Share, Diluted for 2023 was -351, a 19864% decline from 2022.
  • Sunshine Biopharma Inc. annual Earnings Per Share, Diluted for 2022 was -1.76, a 63% increase from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

Sunshine Biopharma Inc. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 -0.82 +42.66 +98% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 -0.44 +1.56 +78% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q2 2024 -43.48 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 -2 +5.73 +74% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 -7.73 -7.5 -3261% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q1 2022 -0.23 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1

Sunshine Biopharma Inc. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -7.32 +344 +98% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 -351 -350 -19864% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
2022 -1.76 +3 +63% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 -4.76 01 Jan 2021 31 Dec 2021 10-K 04 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.